VILIP-1 Downregulation in Non-Small Cell Lung Carcinomas: Mechanisms and Prediction of Survival

• Jian Fu,

  Affiliation Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America

  ⨯
• Kathryn Fong,

  Affiliation Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America

  ⨯
• Alfonso Bellacosa,

  Affiliation Human Genetics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America

  ⨯
• Eric Ross,

  Affiliation Biomathematics and Biostatistics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America

  ⨯
• Sinoula Apostolou,

  Affiliation Bioinformatics Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America

  ⨯
• Daniel E. Bassi,

  Affiliation Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America

  ⨯
• Fang Jin,

  Affiliation Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America

  ⨯
• Jirong Zhang,

  Affiliation Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America

  ⨯
• Paul Cairns,

  Affiliation Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America

  ⨯
• Inmaculada Ibañez de Caceres,

  Affiliation Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America

  ⨯
• Karl-Heinz Braunewell,

  Affiliation Neuroscience Research Center of the Charité, Faculty of Medicine, Humboldt University, Berlin, Germany

  ⨯
• Andres J. Klein-Szanto

  *To whom correspondence should be addressed. E-mail: aj_klein-szanto@fccc.edu

  Affiliation Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America

  ⨯